… SARS-CoV-2 was first detected in Italy in a couple of Chinese tourists coming from Wuhan
on 31 January [2]. Subsequent evaluations have not shown a relationship between the …

… the first few months of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
evolution in a new host, contrasting hypotheses have been proposed about the way the virus has …

… In contrast, several studies report a sustained antibody response in the first 3 months after
SARS-CoV-2 infection, but these studies report changes in binding antibodies only 34,37,38 . …

… The first phase I trial, of the Moderna/VRC vaccine, began in March 2020—barely 3 months
after SARS-CoV-2 was reported for the first time. For several of the candidates described …

… The past several months have witnessed the emergence of SARS-CoV-2 variants with …
aspects of the COVID-19 pandemic. These variants can increase rates of virus transmission and/…

… the time frame of only three months after first vaccination, where … two sub-cohorts: Cohort
1A from the first dose to two weeks after the first dose, and Cohort 1B from 15 days after the first …

… reduction from 825 to 287 AU/ml within the first 3 months (p < 0.0001, an unpaired t-test with
Welch’s correction), and further to 153 AU/ml at the 6-month time points (p = 0.0033) (Fig. 1c…

… COVID-19, multiple symptoms are present about 3 months after symptoms onset. This suggests
the presence of a “post-COVID-19 syndrome… of patients with “mild” or “severe” COVID-19. …

… 3]. In a study conducted among 829 patients recovered from COVID-19, 87 had no detectable
IgG against SARS-CoV-2, of whom 25 (28.7%) were reinfected 1–3 months after their first …

… Interestingly, IgA levels were maintained in those individuals who did not serorevert
during the first 3 months PSO. Furthermore, IgG to N C-terminal rapidly decreased below the …